Education
About Us
Working with TipRanks
Follow Us
Nanexa AB (DE:40M)
FRANKFURT:40M
40M Stock Chart & Stats
€0.29
>-€0.01(-2.14%)
At close: 4:00 PM EST
€0.29
>-€0.01(-2.14%)
Day’s Range― - ―
52-Week Range€0.07 - €0.24
Previous CloseN/A
Volume0.00
Average Volume (3M)6.00
Market Cap
€44.38M
Enterprise Value€348.71M
Total Cash (Recent Filing)€24.78M
Total Debt (Recent Filing)€21.37M
Price to Earnings (P/E)―
Beta1.00
Next Earnings
Feb 12, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding158,676,150
10 Day Avg. Volume20
30 Day Avg. Volume6
Financial Highlights & Ratios
PEG Ratio0.14
Price to Book (P/B)4.13
Price to Sales (P/S)12.03
P/FCF Ratio-5.37
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Nanexa AB News
40M FAQ
What was Nanexa AB’s price range in the past 12 months?
Nanexa AB lowest stock price was €0.07 and its highest was €0.24 in the past 12 months.
What is Nanexa AB’s market cap?
Nanexa AB’s market cap is €44.38M.
When is Nanexa AB’s upcoming earnings report date?
Nanexa AB’s upcoming earnings report date is Feb 12, 2026 which is in 58 days.
How were Nanexa AB’s earnings last quarter?
Nanexa AB released its earnings results on Nov 06, 2025. The company reported -€0.007 earnings per share for the quarter, missing the consensus estimate of N/A by -€0.007.
Is Nanexa AB overvalued?
According to Wall Street analysts Nanexa AB’s price is currently Overvalued.
Does Nanexa AB pay dividends?
Nanexa AB does not currently pay dividends.
What is Nanexa AB’s EPS estimate?
Nanexa AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Nanexa AB have?
Nanexa AB has 158,676,150 shares outstanding.
What happened to Nanexa AB’s price movement after its last earnings report?
Nanexa AB reported an EPS of -€0.007 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -7.143%.
Which hedge fund is a major shareholder of Nanexa AB?
Currently, no hedge funds are holding shares in DE:40M
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Nanexa AB
Nanexa AB (publ) operates as a nanotechnology drug delivery company. It operates PharmaShell, a nanobased drug delivery platform that is an atomic layer deposition. The company also develops NEX-18, which drives the development of a PharmaShell that targets myelodysplastic Syndrome and Acute Myeloid Leukemia. Nanexa AB (publ) was founded in 2007 and is based in Uppsala, Sweden.
Technical Analysis
AlzeCure Pharma AB
―
Vivesto AB
―
Klaria Pharma Holding AB
―
Enzymatica AB
―
Enorama Pharma AB
―